Health Insurance Innovations (HIIQ) — Sell-off Overdone Shares fell sharply (18%) on Q3 2014 results during yesterday’s trading session.The reason for the drop in price was probably because the company missed EPS estimates which resulted in the company showing no […]
Yesterday, we locked in our gains on our short call from 10/20/2014. In our 10/20/2014 note, we stated we were establishing a short position in LAKE based on a 13D/A filing from Ansell (large competitor)showing they had sold the majority of their […]
We may look to add to our long position of PFHO ($45.00) For a while, GeoInvesting has been following Pacific Healthcare Organization. Our very first mention of PFHO was 3/19/12, when we added it to our Tier 1 Pink screen. […]
Lakeland Industries (LAKE) – Short position Established LAKE (16.98; marked down to $15.00 pre market)– Recall, on 10/10/2014 we mentioned we sold our entire position in LAKE. “We first coded LAKE as a GeoSpecial on 2/6/2012 at $10.16 as a possible buyout […]
Repro-Med Systems (OOTC:REPR) ($0.27) – ThisGeoBargain on the radar REPR engages in the design, manufacture, and marketing of proprietary medical devices primarily for emergency medical applications and ambulatory infusion therapy worldwide. Reported Q2 2014 results. REPR reported $2.5 million and […]
Sold our long positions in ERB and SENR In our 10/13/2014 call to action we stated we were initiating long positions in ERB and SENR due to other segments of the Ebola hype began to gain attention. We have now […]
Ocean Bio-Chem (OBCI) – If Falls Below $4.00, We are Buyers We will possibly look to add to our GeoBargain OBCI ($4.92) position if shares fall below $4.00. Ebola trades have certainly become more complicated as several reports are stating that […]
Ibio (AMEX:IBIO) Price Movement From Ebola/Enterovirus Hype Ibio (AMEX:IBIO) ($1.47) is a leading provider of plant-based biotechnology for developing and manufacturing biological products. As expected, the hype surrounding the Ebola and Enterorvirus outbreaks in the U.S. will inevitably led to aggressive share price […]